Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page
- Check2 days agoChange DetectedA new revision (v3.5.0) was added to the record history, and an older revision (v3.4.3) was removed. This is a metadata/version-history change rather than an update to trial content.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed from the history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed in the Study Record History; this routine site-release change does not affect study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page history now shows Revision: v3.4.1, replacing Revision: v3.4.0. This is a minor metadata update to the page.SummaryDifference0.1%

- Check52 days agoChange DetectedUI updates to the record history page add a glossary toggle, color-coded highlights for additions and deletions, and update the revision label to v3.4.0.SummaryDifference1%

- Check66 days agoChange DetectedThe record history now includes an added Revision: v3.3.4 and the removal of Revision: v3.3.3, a minor update to the history log that does not affect study data or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.